Literature DB >> 31094704

Protective role of B cells in sterile particulate-induced lung injury.

Shaikh M Atif1, Douglas G Mack1, Amy S McKee1, Javier Rangel-Moreno2, Allison K Martin1, Andrew Getahun3, Lisa A Maier1,4, John C Cambier3, Rubin Tuder1, Andrew P Fontenot1,3.   

Abstract

Susceptibility to chronic beryllium (Be) disease is linked to HLA-DP molecules possessing a glutamic acid at the 69th position of the β-chain (βGlu69), with the most prevalent βGlu69-containing molecule being HLA-DP2. We have previously shown that HLA-DP2 transgenic (Tg) mice exposed to Be oxide (BeO) develop mononuclear infiltrates in a peribronchovascular distribution and a beryllium-specific, HLA-DP2-restricted CD4+ T cell response. In addition to T cells, B cells constituted a major portion of infiltrated leukocytes in the lung of BeO-exposed HLA-DP2 Tg mice and sequester BeO particles within ectopic lymphoid aggregates and granulomas. B cell depletion was associated with a loss of lymphoid aggregates and granulomas as well as a significant increase in lung injury in BeO-exposed mice. The protective role of B cells was innate in origin, and BeO-induced B cell recruitment to the lung was dependent on MyD88 signaling. Similar to BeO-exposed HLA-DP2 mice, B cells also accumulate in the lungs of CBD subjects, located at the periphery and surrounding the granuloma. Overall, our data suggest a novel modulatory role for B cells in the protection of the lung against sterile particulate exposure, with B cell recruitment to the inflamed lung occurring in an antigen-independent and MyD88-dependent manner.

Entities:  

Keywords:  Adaptive immunity; B cells; Chemokines; Immunology; Pulmonology

Year:  2019        PMID: 31094704      PMCID: PMC6629102          DOI: 10.1172/jci.insight.125494

Source DB:  PubMed          Journal:  JCI Insight        ISSN: 2379-3708


  50 in total

1.  Suppression of IgE responses in CD23-transgenic animals is due to expression of CD23 on nonlymphoid cells.

Authors:  M Payet-Jamroz; S L Helm; J Wu; M Kilmon; M Fakher; A Basalp; J G Tew; A K Szakal; N Noben-Trauth; D H Conrad
Journal:  J Immunol       Date:  2001-04-15       Impact factor: 5.422

Review 2.  Chemokines and cell migration in secondary lymphoid organs.

Authors:  J G Cyster
Journal:  Science       Date:  1999-12-10       Impact factor: 47.728

3.  CXCL13 is required for B1 cell homing, natural antibody production, and body cavity immunity.

Authors:  K Mark Ansel; Ruth B S Harris; Jason G Cyster
Journal:  Immunity       Date:  2002-01       Impact factor: 31.745

4.  HLA-DP allele-specific T cell responses to beryllium account for DP-associated susceptibility to chronic beryllium disease.

Authors:  G Lombardi; C Germain; J Uren; M T Fiorillo; R M du Bois; W Jones-Williams; C Saltini; R Sorrentino; R Lechler
Journal:  J Immunol       Date:  2001-03-01       Impact factor: 5.422

5.  Beryllium presentation to CD4+ T cells underlies disease-susceptibility HLA-DP alleles in chronic beryllium disease.

Authors:  A P Fontenot; M Torres; W H Marshall; L S Newman; B L Kotzin
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

6.  Target organ localization of memory CD4(+) T cells in patients with chronic beryllium disease.

Authors:  Andrew P Fontenot; Scott J Canavera; Laia Gharavi; Lee S Newman; Brian L Kotzin
Journal:  J Clin Invest       Date:  2002-11       Impact factor: 14.808

7.  Human leukocyte antigen Class II amino acid epitopes: susceptibility and progression markers for beryllium hypersensitivity.

Authors:  Milton D Rossman; Jose Stubbs; Chung Wha Lee; Elias Argyris; Eleni Magira; Dimitri Monos
Journal:  Am J Respir Crit Care Med       Date:  2002-03-15       Impact factor: 21.405

Review 8.  HLA-DPB1 and chronic beryllium disease: a HuGE review.

Authors:  Erin C McCanlies; Kathleen Kreiss; Michael Andrew; Ainsley Weston
Journal:  Am J Epidemiol       Date:  2003-03-01       Impact factor: 4.897

9.  Efficacy of a technique for exposing the mouse lung to particles aspirated from the pharynx.

Authors:  G V S Rao; Sally Tinkle; David N Weissman; James M Antonini; Michael L Kashon; Rebecca Salmen; Lori A Battelli; Patsy A Willard; Mark D Hoover; Ann F Hubbs
Journal:  J Toxicol Environ Health A       Date:  2003-08-08

10.  Surface area of respirable beryllium metal, oxide, and copper alloy aerosols and implications for assessment of exposure risk of chronic beryllium disease.

Authors:  Aleksandr B Stefaniak; Mark D Hoover; Robert M Dickerson; Eric J Peterson; Gregory A Day; Patrick N Breysse; Michael S Kent; Ronald C Scripsick
Journal:  AIHA J (Fairfax, Va)       Date:  2003 May-Jun
View more
  7 in total

1.  Beryllium-specific CD4+ T cells induced by chemokine neoantigens perpetuate inflammation.

Authors:  Michael T Falta; Jeremy C Crawford; Alex N Tinega; Laurie G Landry; Frances Crawford; Douglas G Mack; Allison K Martin; Shaikh M Atif; Li Li; Radleigh G Santos; Maki Nakayama; John W Kappler; Lisa A Maier; Paul G Thomas; Clemencia Pinilla; Andrew P Fontenot
Journal:  J Clin Invest       Date:  2021-05-03       Impact factor: 14.808

Review 2.  Innate and Adaptive Immunity in Noninfectious Granulomatous Lung Disease.

Authors:  Amy S McKee; Shaikh M Atif; Michael T Falta; Andrew P Fontenot
Journal:  J Immunol       Date:  2022-04-15       Impact factor: 5.426

3.  A role for TNF-α in alveolar macrophage damage-associated molecular pattern release.

Authors:  Morgan K Collins; Abigail M Shotland; Morgan F Wade; Shaikh M Atif; Denay K Richards; Manolo Torres-Llompart; Douglas G Mack; Allison K Martin; Andrew P Fontenot; Amy S McKee
Journal:  JCI Insight       Date:  2020-05-07

Review 4.  Clinical Presentations, Pathogenesis, and Therapy of Sarcoidosis: State of the Art.

Authors:  Francesca Polverino; Elisabetta Balestro; Paolo Spagnolo
Journal:  J Clin Med       Date:  2020-07-24       Impact factor: 4.241

Review 5.  Adaptive Immunity in Pulmonary Sarcoidosis and Chronic Beryllium Disease.

Authors:  Sarah A Greaves; Shaikh M Atif; Andrew P Fontenot
Journal:  Front Immunol       Date:  2020-03-18       Impact factor: 7.561

6.  Mouse innate-like B-1 lymphocytes promote inhaled particle-induced in vitro granuloma formation and inflammation in conjunction with macrophages.

Authors:  Léa Hiéronimus; Raïssa Demazy; Laura Christiaens; Francine Uwambayinema; Jean-François Geuens; Youssof Yacoub; François Huaux
Journal:  Arch Toxicol       Date:  2021-12-21       Impact factor: 5.153

7.  Protective role of tissue-resident Tregs in a murine model of beryllium-induced disease.

Authors:  Shaikh M Atif; Douglas G Mack; Allison K Martin; Andrew P Fontenot
Journal:  JCI Insight       Date:  2022-08-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.